P632: COMPARISON OF TREATMENT-EMERGENT ADVERSE EVENTS OF ACALABRUTINIB AND ZANUBRUTINIB IN CLINICAL TRIALS IN B-CELL MALIGNANCIES: A SYSTEMATIC REVIEW AND META-ANALYSIS

• Steven Hwang,
• Jacqueline Wang,
• Zizhong Tian,
• Xinyue Qi,
• Yi Jiang,
• Shijia Zhang,
• Richard C. Godby,
• Sameer Parikh,
• Wei Ding,
• Paul Hampel,
• Javier Munoz,
• Jonas Paludo,
• Saad Kenderian,
• Eli Muchtar,
• Mazie Tsang,
• Talal Hilal,
• Jose Leis,
• Gita Thanarajasingam,
• David Inwards,
• Grzegorz S. Nowakowski,
• Stephen Ansell,
• Thomas Habermann,
• Thomas Witzig,
• Neil Kay,
• Shouhao Zhou,
• Yucai Wang

Affiliations

Steven Hwang

1 Mayo Clinic, Division of Hematology, Rochester, United States

Jacqueline Wang

2 NYU Langone Health, Department of Medicine, New York, United States

Zizhong Tian

3 Penn State College of Medicine, Department of Public Health Sciences, Division of Biostatistics and Bioinformatics, Hershey, United States

Xinyue Qi

3 Penn State College of Medicine, Department of Public Health Sciences, Division of Biostatistics and Bioinformatics, Hershey, United States

Yi Jiang

3 Penn State College of Medicine, Department of Public Health Sciences, Division of Biostatistics and Bioinformatics, Hershey, United States

Shijia Zhang

4 Peoria - Illinois CancerCare PC, Peoria, United States

Richard C. Godby

1 Mayo Clinic, Division of Hematology, Rochester, United States

Sameer Parikh

1 Mayo Clinic, Division of Hematology, Rochester, United States

Wei Ding

1 Mayo Clinic, Division of Hematology, Rochester, United States

Paul Hampel

1 Mayo Clinic, Division of Hematology, Rochester, United States

Javier Munoz

5 Mayo Clinic, Division of Hematology, Phoenix, United States

Jonas Paludo

1 Mayo Clinic, Division of Hematology, Rochester, United States

Saad Kenderian

1 Mayo Clinic, Division of Hematology, Rochester, United States

Eli Muchtar

1 Mayo Clinic, Division of Hematology, Rochester, United States

Mazie Tsang

5 Mayo Clinic, Division of Hematology, Phoenix, United States

Talal Hilal

5 Mayo Clinic, Division of Hematology, Phoenix, United States

Jose Leis

5 Mayo Clinic, Division of Hematology, Phoenix, United States

Gita Thanarajasingam

1 Mayo Clinic, Division of Hematology, Rochester, United States

David Inwards

1 Mayo Clinic, Division of Hematology, Rochester, United States

Grzegorz S. Nowakowski

1 Mayo Clinic, Division of Hematology, Rochester, United States

Stephen Ansell

1 Mayo Clinic, Division of Hematology, Rochester, United States

Thomas Habermann

1 Mayo Clinic, Division of Hematology, Rochester, United States

Thomas Witzig

1 Mayo Clinic, Division of Hematology, Rochester, United States

Neil Kay

1 Mayo Clinic, Division of Hematology, Rochester, United States

Shouhao Zhou

3 Penn State College of Medicine, Department of Public Health Sciences, Division of Biostatistics and Bioinformatics, Hershey, United States

Yucai Wang

1 Mayo Clinic, Division of Hematology, Rochester, United States